Al Nahdi Medical Company SJSC Stock

Al Nahdi Medical Company SJSC Equity 2024

Al Nahdi Medical Company SJSC Equity

2.46 B SAR

Ticker

4164.SR

ISIN

SA15HG521213

In 2024, Al Nahdi Medical Company SJSC's equity was 2.46 B SAR, a 9.78% increase from the 2.24 B SAR equity in the previous year.

Al Nahdi Medical Company SJSC Aktienanalyse

What does Al Nahdi Medical Company SJSC do?

Al Nahdi Medical Company SJSC ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Al Nahdi Medical Company SJSC's Equity

Al Nahdi Medical Company SJSC's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Al Nahdi Medical Company SJSC's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Al Nahdi Medical Company SJSC's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Al Nahdi Medical Company SJSC's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Al Nahdi Medical Company SJSC’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Al Nahdi Medical Company SJSC stock

What is the equity of Al Nahdi Medical Company SJSC this year?

Al Nahdi Medical Company SJSC has equity of 2.46 B SAR this year.

What was the equity of Al Nahdi Medical Company SJSC compared to the previous year?

The equity of Al Nahdi Medical Company SJSC has increased/decreased by 9.78% increased compared to the previous year.

What impact does a high equity have on investors of Al Nahdi Medical Company SJSC?

A high equity is advantageous for investors of Al Nahdi Medical Company SJSC as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Al Nahdi Medical Company SJSC?

A low equity can be a risk for investors of Al Nahdi Medical Company SJSC, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Al Nahdi Medical Company SJSC affect the company?

An increase in equity of Al Nahdi Medical Company SJSC can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Al Nahdi Medical Company SJSC affect the company?

A reduction in equity of Al Nahdi Medical Company SJSC can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Al Nahdi Medical Company SJSC?

Some factors that can affect the equity of Al Nahdi Medical Company SJSC include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Al Nahdi Medical Company SJSC so important for investors?

The equity of Al Nahdi Medical Company SJSC is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Al Nahdi Medical Company SJSC take to change the equity?

To change equity, Al Nahdi Medical Company SJSC can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Al Nahdi Medical Company SJSC pay?

Over the past 12 months, Al Nahdi Medical Company SJSC paid a dividend of 5.5 SAR . This corresponds to a dividend yield of about 4.21 %. For the coming 12 months, Al Nahdi Medical Company SJSC is expected to pay a dividend of 6.94 SAR.

What is the dividend yield of Al Nahdi Medical Company SJSC?

The current dividend yield of Al Nahdi Medical Company SJSC is 4.21 %.

When does Al Nahdi Medical Company SJSC pay dividends?

Al Nahdi Medical Company SJSC pays a quarterly dividend. This is distributed in the months of April, September, April, September.

How secure is the dividend of Al Nahdi Medical Company SJSC?

Al Nahdi Medical Company SJSC paid dividends every year for the past 5 years.

What is the dividend of Al Nahdi Medical Company SJSC?

For the upcoming 12 months, dividends amounting to 6.94 SAR are expected. This corresponds to a dividend yield of 5.31 %.

In which sector is Al Nahdi Medical Company SJSC located?

Al Nahdi Medical Company SJSC is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Al Nahdi Medical Company SJSC kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Al Nahdi Medical Company SJSC from 8/25/2024 amounting to 2.5 SAR, you needed to have the stock in your portfolio before the ex-date on 8/12/2024.

When did Al Nahdi Medical Company SJSC pay the last dividend?

The last dividend was paid out on 8/25/2024.

What was the dividend of Al Nahdi Medical Company SJSC in the year 2023?

In the year 2023, Al Nahdi Medical Company SJSC distributed 2.31 SAR as dividends.

In which currency does Al Nahdi Medical Company SJSC pay out the dividend?

The dividends of Al Nahdi Medical Company SJSC are distributed in SAR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Al Nahdi Medical Company SJSC

Our stock analysis for Al Nahdi Medical Company SJSC Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Al Nahdi Medical Company SJSC Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.